Security Snapshot

iBio, Inc. - Common Stock, par value $0.001 per share (IBIO) Institutional Ownership

CUSIP: 451033708

13F Institutional Holders and Ownership History from Q1 2023 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

52

Shares (Excl. Options)

19,427,041

Price

$1.90

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+2,671,949
Value change
+$4,998,745
Number of holders
52
Issuer context Who this page is about. 2 identity fields
Shares outstanding
117,033,737
SEC-reported price per share
$1.61
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • IBIO - iBio, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 451033708.
  • 52 institutions reported positions in Q1 2026.
  • 14 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 49 to 52 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $31,555,271 to $36,911,652.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 52 institutions filings for Q1 2026.

Open SEC evidence

Security key

451033708

Latest holder period

Q1 2026

13F holders

52

13D/G owners

14

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
14
Security
IBIO
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Sirenia Capital Management LP 9.9% $25,489,948 11,586,340 Sirenia Capital Management LP 31 Mar 2026
Vestal Point Capital, LP 9.9% $3,518,752 4,275,000 Vestal Point Capital, LP 30 Sep 2025
Affinity Asset Advisors, LLC 10% 0% $7,675,906 +$2,392,350 3,489,048 +45% Affinity Asset Advisors, LLC 31 Mar 2026
Cormorant Asset Management, LP 10% $1,850,337 2,248,010 Cormorant Asset Management, LP 30 Sep 2025
EcoR1 Capital, LLC 9.9% $2,673,600 2,228,000 EcoR1 Capital, LLC 10 Dec 2025
SILVERARC CAPITAL MANAGEMENT, LLC 10% $1,795,528 2,181,422 SilverArc Capital Management, LLC 30 Sep 2025
Adage Capital Management, L.P. 10% $1,795,528 2,181,422 Adage Capital Management, L.P. 30 Sep 2025
Frazier Life Sciences Public Fund, L.P. 8.7% $2,344,160 1,953,467 Frazier Life Sciences Public Fund, L.P. 09 Dec 2025
Logos Global Management LP 4.6% -48% $3,810,000 -$1,270,000 1,500,000 -25% Logos Global Management LP 31 Dec 2025
ADAR1 Capital Management, LLC 4.4% -55% $3,433,244 -$1,123,655 1,351,671 -25% ADAR1 Capital Management, LLC 31 Dec 2025
INTEGRATED CORE STRATEGIES (US) LLC 5.2% $2,381,068 1,235,827 Millennium Management LLC 15 Jan 2026
Ikarian Capital, LLC 5% $947,430 1,151,051 Ikarian Capital, LLC 30 Sep 2025
Crutcher Patrick J 3.1% -56% $635,283 +$112,748 847,044 +22% Patrick J. Crutcher 30 Jun 2025
Opaleye Management Inc. 7.6% $787,500 750,000 Opaleye Management, Inc. 31 Dec 2024

As of 31 Mar 2026, 52 institutional investors reported holding 19,427,041 shares of iBio, Inc. - Common Stock, par value $0.001 per share (IBIO). This represents 17% of the company’s total 117,033,737 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
16%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Affinity Asset Advisors, LLC 2.7% 3,107,200 +51% 0.35% $5,903,680
Frazier Life Sciences Management, L.P. 1.7% 1,953,467 0% 0.1% $3,711,587
EcoR1 Capital, LLC 1.4% 1,583,000 -29% 0.13% $3,007,700
MILLENNIUM MANAGEMENT LLC 1.3% 1,549,850 0% $2,944,715
Logos Global Management LP 1.1% 1,300,000 -35% 0.13% $2,470,000
VANGUARD CAPITAL MANAGEMENT LLC 0.93% 1,088,299 0% 0% $2,067,768
Balyasny Asset Management L.P. 0.86% 1,010,955 -7.8% 0% $1,920,815
Ikarian Capital, LLC 0.82% 957,062 0% 0.26% $1,818,418
CITADEL ADVISORS LLC 0.82% 956,429 0% $1,817,215
Sio Capital Management, LLC 0.77% 904,268 +22% 0.25% $1,718,109
MARSHALL WACE, LLP 0.53% 620,602 +412% 0% $1,179,144
ADAR1 Capital Management, LLC 0.4% 469,878 +16% 0.05% $892,768
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.35% 412,725 0% $784,178
TWO SIGMA INVESTMENTS, LP 0.35% 408,858 -10% 0% $776,830
Walleye Capital LLC 0.33% 388,554 +96% 0% $738,253
GEODE CAPITAL MANAGEMENT, LLC 0.33% 387,567 +74% 0% $736,602
NOESIS CAPITAL MANGEMENT CORP 0.27% 311,500 +39% 0.09% $591,850
BANK OF AMERICA CORP /DE/ 0.25% 290,413 +151% 0% $551,785
BOOTHBAY FUND MANAGEMENT, LLC 0.22% 254,412 0% 0.01% $483,383
SILVERARC CAPITAL MANAGEMENT, LLC 0.19% 226,000 +113% 0.05% $429,400
VANGUARD FIDUCIARY TRUST CO 0.18% 205,015 0% 0% $389,529
GOLDMAN SACHS GROUP INC 0.17% 200,212 0% $380,403
DAFNA Capital Management LLC 0.17% 193,638 0.08% $367,912
STATE STREET CORP 0.12% 141,199 +94% 0% $268,278
BlackRock, Inc. 0.11% 131,215 +207% 0% $249,309

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
13
Latest
Q1 2026
Rows shown
1-13 of 13
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 19,427,041 $36,911,652 +$4,998,745 $1.90 52
2025 Q4 16,339,467 $31,555,271 +$26,570,216 $1.93 49
2025 Q3 3,569,988 $2,955,323 +$299,071 $0.83 32
2025 Q2 3,204,109 $2,444,153 -$225,284 $0.76 30
2025 Q1 2,587,118 $10,399,905 +$550,651 $4.02 33
2024 Q4 2,612,402 $6,400,381 +$11,561 $2.45 29
2024 Q3 2,607,512 $5,788,674 +$356,141 $2.22 31
2024 Q2 2,451,117 $5,171,853 -$1,674,085 $2.11 26
2024 Q1 2,885,311 $11,469,753 +$10,566,308 $4.06 26
2023 Q4 251,385 $344,588 +$344,585 $1.37 20
2023 Q3 0 $0 -$5 $1.61 0
2023 Q2 8 $5 $0.62 1
2023 Q1 8 $17 +$17 $2.12 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .